NovaBay Pharmaceuticals
13 hedge funds and large institutions have $127K invested in NovaBay Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24.7K | |
| 2 | +$19.1K | |
| 3 | +$3.91K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.51K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$266 |
Top Sellers
| 1 | -$128K | |
| 2 | -$6.18K | |
| 3 | -$674 | |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$31 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3 |